MktsMarkets

Orchestra BioMed Holdings, Inc.
NASDAQ: OBIOKey statistics
OBIO News
Stories mentioning OBIO from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 110.00 | 30,917 | 861.00 | 836.00 | 868.00 | 253.00 | 987.00 | 778.00 |
| Cost of Goods Sold | 32.00 | 51.00 | 49.00 | 46.00 | 44.00 | 58.00 | 68.00 | 44.00 |
| Gross Profit | 78.00 | 30,866 | 812.00 | 790.00 | 824.00 | 195.00 | 919.00 | 734.00 |
| Operating Expenses | ||||||||
| Research & Development | 15,781 | 16,823 | 14,027 | 13,853 | 13,482 | 10,971 | 11,595 | 11,126 |
| Sales General & Admin | 6,373 | 7,289 | 7,098 | 6,264 | 6,263 | 5,901 | 5,666 | 6,467 |
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | (22,076) | 6,754 | (20,313) | (19,327) | (18,921) | (16,677) | (16,342) | (16,859) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | ||||||||
| Pretax Income | ||||||||
| Tax Provision | ||||||||
| Net Income (Loss) | (20,691) | 6,245 | (20,828) | (19,363) | (18,755) | (16,155) | (15,426) | (15,980) |
| Earnings Per Share (Basic) | (0.33) | 0.13 | (0.40) | (0.50) | (0.49) | (0.44) | (0.41) | (0.45) |
| Earnings Per Share (Diluted) | (0.33) | 0.13 | (0.40) | (0.50) | (0.49) | (0.44) | (0.41) | (0.45) |
| Weighted Average Shares Outstanding (Basic) | 62,722 | 47,747 | 52,187 | 38,393 | 38,235 | 36,821 | 37,621 | 35,800 |
| Weighted Average Shares Outstanding (Diluted) | 62,722 | 47,747 | 52,187 | 38,393 | 38,235 | 36,821 | 37,621 | 35,800 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About OBIO
Orchestra BioMed Holdings, Inc. (NASDAQ: OBIO) is a stock listed on the Nasdaq Stock Market under the ticker symbol OBIO. It last traded at $5.70 (Nov 2, 2026, 1:31 PM ET), down 3.5% on the day. That gives Orchestra BioMed a market capitalisation of $355.2M.
Over the past 52 weeks OBIO has traded between $3.46 and $6.50.
Revenue for the quarter ended Mar 31, 2026 was $110.0K; a net loss of $20.7M. Revenue was down 87.3% from $868.0K in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $110.0K | -$20.7M | -18810.0% |
| Dec 31, 2025 | $30.9M | $6.2M | 20.2% |
| Sep 30, 2025 | $861.0K | -$20.8M | -2419.0% |
| Jun 30, 2025 | $836.0K | -$19.4M | -2316.1% |
From Orchestra BioMed’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…